Share this article

 Email

 Print

 

Republish this article

The text of this article by Futurity is licensed under a Creative Commons Attribution-No Derivatives License.

More
Health & Medicine

‘Master switch’ may be key to brain cancer

Lower obesity rates for kids in traditional families

Daily calcium linked to longer life in women

Drug blunts cocaine addiction in mice

Where visual search happens in the brain

Childhood CT scans slightly raise cancer risk

Polio virus engineered to kill brain tumor

Cartilage gets bum rap for osteoarthritis

How to decide if a daily aspirin is harmful

The findings, published in PLOS ONE, offer hope that such milk may eventually help prevent human diarrheal diseases that each year claim the lives of 1.8 million children around the world and impair the physical and mental development of millions more.

“Many developing parts of the world rely on livestock as a main source of food,” says James Murray, an animal science and veterinary medicine professor at University of California, Davis and lead researcher on the study.

“These results provide just one example that, through genetic engineering, we can provide agriculturally relevant animals with novel traits targeted at solving some of the health-related problems facing these developing communities.”

In this study, Murray and colleagues fed young pigs milk from goats that were genetically modified to produce in their milk higher levels of lysozyme, a protein that naturally occurs in the tears, saliva, and milk of all mammals.

Although lysozyme is produced at very high levels in human breast milk, the milk of goats and cows contains very little lysozyme, which prompted the effort to boost lysozyme levels in the milk of those animals using genetic modification.

Because lysozyme limits the growth of some bacteria that cause intestinal infections and diarrhea and also encourages the growth of other beneficial intestinal bacteria, it is considered one of the main components of human milk that contribute to the health and well-being of breast-fed infants.

Pigs were chosen for this study as a research model because their gastrointestinal physiology is quite similar to that of humans, and because pigs already produce a moderate amount of lysozyme in their milk.

Half of the pigs in the study were fed pasteurized milk that came from the transgenic goats and carried greater amounts of lysozyme—68 percent of the level found in human breast milk. The other half of the pigs were fed pasteurized milk that came from nontransgenic goats and thus contained very little lysozyme.

The study finds that, although both groups of pigs recovered from the infection and resulting diarrhea, the young pigs fed the lysozyme-rich milk recovered much more quickly than did the young pigs that received goats’ milk without enhanced levels of lysozyme.

Overall, the pigs fed the lysozyme milk were less dehydrated, had less intestinal inflammation, suffered less damage to the inner intestines, and regained their energy more quickly than did the pigs in the control group.

And, the researchers detected no adverse effects associated with the lysozyme-rich milk.

The lysozyme-enhanced milk used in this study came from a transgenic line of dairy goats developed in 1999 by Murray, co-author Elizabeth Maga, and their colleagues to carry the gene for producing human lysozyme in their milk.

The UC Davis College of Agricultural and Environmental Sciences and the UC Agricultural Experiment Station provided funding for the research.

Source: UC Davis